Aubrey Rankin
Overview
Aubrey Rankin received $3M in total compensation, including $395K in salary, at Revance Therapeutics in 2021.
Source: SEC filing on March 24, 2022.
Related executives
We found 12 more executives who work or worked at Revance Therapeutics.
Mark Foley
Revance Therapeutics
Chief Executive Officer
Dustin Sjuts
Revance Therapeutics
President
Abhay Joshi
Revance Therapeutics
Chief Operating Officer
Tobin Schilke
Revance Therapeutics
Chief Financial Officer
Dwight Moxie
Revance Therapeutics
General Counsel
L Browne
Revance Therapeutics
Chief Executive Officer
Caryn McDowell
Revance Therapeutics
General Counsel
Todd Zavodnick
Revance Therapeutics